Subjects wore a therapeutic or sham device prior to the usual onset of symptoms for a minimum of 1 h daily. Measures of severity of illness, quality of life, daytime sleepiness, and fatigue were ...

The FDA clearance was based on data from a randomized, sham-controlled study that evaluated the safety and efficacy of the vibration therapy device in postmenopausal women with osteopenia.